SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: drdan who wrote (1234)6/18/1998 2:50:00 PM
From: RocketMan  Read Replies (2) of 5402
 
drdan, I agree 100%. SGNC is NOT a short term play, and there is a great deal of DD to do before we can feel totally comfortable. The Batelle contract only says that the technology is sufficiently promising for a national laboratory to invest in it. And that is only for initial animal trials, I assume (I am not a medical person). So although I am happy with the contract announcement, I also realize this has a long way to go. The last thing we want is a quick runup in the price, with the attendant scrutiny, naysayers, etc. I do believe this company will rise on its own merits, which is why I am invested in it. This company needs NO HYPE!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext